Warning: Undefined array key "options" in /srv/users/insolvency-insider-editor/apps/video-webinars/public/wp-content/plugins/elementor-pro/modules/theme-builder/widgets/site-logo.php on line 93

Q3 2023: CCAA applications refused; sales processes clarified

November 2023

Agenda

Are the courts becoming more stringent in their review of CCAA applications? Is it appropriate for courts to make findings of fact on disputed issues in chambers?

Join us for an informative 45-minute discussion in which our expert panel considers these questions, together with the implications of a number of significant recent cases. We’ll cover, among other things:

  • a couple of cases in the last quarter where the courts have refused to grant CCAA orders;
  • whether and when disputed issues can be resolved in chambers;
  • the court’s recognition of a roll-up DIP approved in US bankruptcy proceedings;
  • whether substantive consolidation can be ordered against solvent entities; and
  • the necessity (or lack thereof) of a public sales process before a sale can be approved.

Panelists

Lee Nicholson, Partner, Stikeman Elliott (Toronto)

Arad Mojtahedi, Senior Associate, Norton Rose Fulbright (Montréal)

Anthony Mersich, Associate, Fasken (Calgary)

Dina Kovacevic, Editor, Insolvency Insider

Who Should Attend:

Trustees and other insolvency professionals

Bankruptcy and insolvency lawyers

Corporate bankers

Liquidators and distressed investors

Commercial lawyers

Corporate counsel

Chartered Professional Accountants

CPD Hours:

The webinar will qualify for a half hour of Continuing Professional Development for lawyers, CPAs and CIRPs.

Q3 2023: CCAA applications refused; sales processes clarified

November 2023

Register now for $79.00 + HST to watch Q3 2023: CCAA applications refused; sales processes clarified

Purchase Webinar Access

Please provide your name, email address and credit card information. After payment, you will immediately be able to watch the webinar. You will also receive an email with a direct link to the webinar.